A majority of companies within Nomura's coverage universe outpaced the broader pharma market in August. Zydus Lifesciences and Glenmark Pharmaceuticals posted the strongest YoY value expansion.
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.